VeraBank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,957
Closed -$256K 175
2026
Q1
$256K Sell
2,957
-44
-1% -$4.21K 0.05% 158
2025
Q4
$288K Sell
3,001
-55
-2% -$5.34K 0.05% 151
2025
Q3
$291K Sell
3,056
-917
-23% -$84.3K 0.05% 154
2025
Q2
$346K Buy
3,973
+293
+8% +$24.8K 0.07% 146
2025
Q1
$331K Sell
3,680
-126
-3% -$11.3K 0.09% 113
2024
Q4
$304K Sell
3,806
-88
-2% -$7.62K 0.09% 117
2024
Q3
$351K Sell
3,894
-130
-3% -$10.9K 0.1% 112
2024
Q2
$317K Hold
4,024
0.1% 114
2024
Q1
$351K Hold
4,024
0.11% 113
2023
Q4
$331K Sell
4,024
-102
-2% -$7.77K 0.11% 113
2023
Q3
$323K Sell
4,126
-50
-1% -$4.19K 0.12% 114
2023
Q2
$368K Hold
4,176
0.14% 104
2023
Q1
$337K Sell
4,176
-1,739
-29% -$142K 0.16% 106
2022
Q4
$460K Buy
5,915
+98
+2% +$7.94K 0.23% 83
2022
Q3
$470K Sell
5,817
-72
-1% -$6.47K 0.3% 74
2022
Q2
$529K Sell
5,889
-584
-9% -$59.2K 0.31% 72
2022
Q1
$718K Sell
6,473
-29
-0.4% -$3.06K 0.37% 63
2021
Q4
$673K Sell
6,502
-28
-0.4% -$3.24K 0.34% 67
2021
Q3
$819K Buy
6,530
+313
+5% +$40.5K 0.46% 54
2021
Q2
$772K Sell
6,217
-418
-6% -$52.5K 0.46% 50
2021
Q1
$784K Hold
6,635
0.51% 48
2020
Q4
$777K Hold
6,635
0.55% 45
2020
Q3
$690K Sell
6,635
-92
-1% -$9.24K 0.53% 47
2020
Q2
$617K Hold
6,727
0.51% 49
2020
Q1
$607K Sell
6,727
-100
-1% -$10.6K 0.59% 47
2019
Q4
$775K Hold
6,827
0.63% 46
2019
Q3
$742K Buy
6,827
+122
+2% +$12.7K 0.67% 45
2019
Q2
$653K Hold
6,705
0.61% 46
2019
Q1
$611K Sell
6,705
-23
-0.3% -$2.06K 0.58% 46
2018
Q4
$612K Buy
+6,728
New +$629K 0.66% 44

Other funds holding MDT

VeraBank's MDT Position: Q2 2026 in Review

VeraBank sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,957 shares — an estimated $256K sold.

VeraBank first reported a position in MDT in Q4 2018 and held it in 30 quarters. The position peaked at $819K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • VeraBank reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • VeraBank sold 2,957 Medtronic shares in Q2 2026, an estimated $256K.
  • VeraBank first reported a position in Medtronic in Q4 2018 and held it in 30 quarters.
  • VeraBank's Medtronic position peaked at $819K in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.